Meet the Medicines—A Crowdsourced Approach to Collecting and Communicating Information about Essential Medicines Online
Abstract
:1. Introduction
Aims of This Paper
2. Methods
2.1. Crowdsourcing Data Collection: E$$ENTIAL MEDICINE$
2.2. Crowdsourcing Communication: Meet the Medicines
- Participants complete a Google Sheet for an essential medicine of their choice, detailing the information they would like to include in their video (e.g., conditions the medicine is used to prevent, manage and/or treat, the general route of administration, accessibility issues, etc.) taken from the E$$ database.
- Participants complete a PowerPoint template choosing the colour scheme and icons from the Icon Pack, write captions and alternative text, adjust timings and export the PowerPoint in video format.
- Following a fact check by the project’s principal scientist (KRS), the final video is disseminated via social media by the project’s management team. Each participant who aided in the creation of the video is credited through their social media handles, with the option to remain anonymous.
3. Results
3.1. Creating an Essential Medicine Accessibility Database
3.1.1. Database Stage I: Regulatory Approvals
3.1.2. Database Stage 2: The Challenges
3.1.3. Database Stage 3: The Future
3.2. Meet the Medicines Communication
3.3. Meet the Medicines: Beginning to End
3.3.1. Data Assembly
3.3.2. Video Creation
3.3.3. Alternative Text and Acknowledgments
3.3.4. Fact Checking and Posting
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. Access to Medicines: Making Market Forces Serve the Poor. Ten Years in Public Health 2007–2017; World Health Organization: Geneva, Switzerland, 2017. [Google Scholar]
- World Health Organization. Access to Essential Medicines, Vaccines and Health Technologies: Fact Sheet on Sustainable Development Goals (SDGs): Health Targets; World Health Organization: Geneva, Switzerland, 2017. [Google Scholar]
- World Health Organization. WHO Model Lists of Essential Medicines. Available online: https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists (accessed on 30 November 2022).
- World Health Organization. Model List of Essential Medicines; 22nd List; World Health Organization: Geneva, Switzerland, 2021. [Google Scholar]
- Bazargani, Y.T.; Ewen, M.; De Boer, A.; Leufkens, H.G.M.; Mantel-Teeuwisse, A.K. Essential Medicines Are More Available than Other Medicines around the Globe. PLoS ONE 2014, 9, e87576. [Google Scholar] [CrossRef] [Green Version]
- Saeed, A.; Saeed, H.; Saleem, Z.; Fang, Y.; Babar, Z.-U.-D. Evaluation of Prices, Availability and Affordability of Essential Medicines in Lahore Division, Pakistan: A Cross-Sectional Survey Using WHO/HAI Methodology. PLoS ONE 2019, 14, e0216122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wirtz, V.J.; Hogerzeil, H.V.; Gray, A.L.; Bigdeli, M.; De Joncheere, C.P.; Ewen, M.A.; Gyansa-Lutterodt, M.; Jing, S.; Luiza, V.L.; Mbindyo, R.M.; et al. Essential Medicines for Universal Health Coverage Executive Summary. Lancet 2017, 389, 476. [Google Scholar] [CrossRef]
- Danza, Á.; Graña, D.; Goñi, M.; Vargas, A.; Ruiz-Irastorza, G. Hydroxychloroquine for Autoimmune Diseases. Rev. Med. Chil. 2016, 144, 232–240. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mendel, A.; Bernatsky, S.; Thorne, J.C.; Lacaille, D.; Johnson, S.R.; Vinet, É. Hydroxychloroquine Shortages during the COVID-19 Pandemic. Ann. Rheum. Dis. 2021, 80, e31. [Google Scholar] [CrossRef] [PubMed]
- Mendel, A.; Bernatsky, S.; Askanase, A.; Bae, S.C.; Clarke, A.E.; Costedoat-Chalumeau, N.; Gladman, D.D.; Gordon, C.; Hanly, J.; Jacobsen, S.; et al. Hydroxychloroquine Shortages among Patients with Systemic Lupus Erythematosus during the COVID-19 Pandemic: Experience of the Systemic Lupus International Collaborating Clinics. Ann. Rheum. Dis. 2021, 80, 1–2. [Google Scholar] [CrossRef]
- Self, W.H.; Semler, M.W.; Leither, L.M.; Casey, J.D.; Angus, D.C.; Brower, R.G.; Chang, S.Y.; Collins, S.P.; Eppensteiner, J.C.; Filbin, M.R.; et al. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients with COVID-19: A Randomized Clinical Trial. JAMA 2020, 324, 2165–2176. [Google Scholar] [CrossRef]
- Reuters, U.S. FDA Says Malaria Drugs in Shortage as Coronavirus Drives up Demand. Available online: https://www.reuters.com/article/us-health-coronavirus-fda-chloroquine-idUSKBN21J5RX (accessed on 30 November 2022).
- Niburski, K.; Niburski, O. Impact of Trump’s Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study. J. Med. Internet Res. 2020, 22, e20044. [Google Scholar] [CrossRef]
- Williamson, A.E. Open Source Drug Discovery: Global Solutions to Global Problems. Aust. Q. 2017, 88, 3–8. [Google Scholar]
- Bosworth, A.; Sheingold, S.; Finegold, K.; De Lew, N.; Sommers, B.D. Price Increases for Prescription Drugs, 2016–2022; Office of the Assistant Secretary for Planning and Evaluation: Washington, DC, USA, 2022. [Google Scholar]
- Alpern, J.D.; Song, J.; Stauffer, W.M. Essential Medicines in the United States—Why Access Is Diminishing. N. Engl. J. Med. 2016, 374, 1904–1907. [Google Scholar] [CrossRef] [Green Version]
- FDA. FDA Drug Competition Action Plan. Available online: https://www.fda.gov/drugs/guidance-compliance-regulatory-information/fda-drug-competition-action-plan (accessed on 15 January 2023).
- Golumbic, Y.N.; Motion, A.; Chau, A.; Choi, L.; D’Silva, D.; Ho, J.; Nielsen, M.; Shi, K.; Son, C.D.; Wu, O.; et al. Self-Reflection Promotes Learning in Citizen Science and Serves as an Effective Assessment Tool. Comput. Educ. Open 2022, 3, 100104. [Google Scholar] [CrossRef]
- Burns, T.W.; O’Connor, D.J.; Stocklmayer, S.M. Science Communication: A Contemporary Definition. Public Underst. Sci. 2003, 12, 183–202. [Google Scholar] [CrossRef] [Green Version]
- Fischhoff, B. The Sciences of Science Communication. Proc. Natl. Acad. Sci. USA 2013, 110, 14033–14039. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Concannon, C.; Grenon, M. Researchers: Share Your Passion for Science! Biochem. Soc. Trans. 2016, 44, 1507–1515. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Golumbic, Y.N.; Orr, D.; Baram-Tsabari, A.; Fishbain, B. Between Vision and Reality: A Case Study of Scientists’ Views on Citizen Science. Citiz. Sci. Theory Pract. 2017, 2, 6. [Google Scholar] [CrossRef] [Green Version]
- Dudo, A.; Besley, J.C. Scientists’ Prioritization of Communication Objectives for Public Engagement. PLoS ONE 2016, 11, e0148867. [Google Scholar] [CrossRef] [Green Version]
- Besley, J.C.; Dudo, A.; Yuan, S.; Lawrence, F. Understanding Scientists’ Willingness to Engage. Sci. Commun. 2018, 40, 559–590. [Google Scholar] [CrossRef] [Green Version]
- Rose, K.M.; Markowitz, E.M.; Brossard, D. Scientists’ Incentives and Attitudes toward Public Communication. Proc. Natl. Acad. Sci. USA 2020, 117, 1274–1276. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kelp, N.C.; Witt, J.K.; Sivakumar, G. To Vaccinate or Not? The Role Played by Uncertainty Communication on Public Understanding and Behavior Regarding COVID-19. Sci. Comm. 2021, 44, 223–239. [Google Scholar] [CrossRef]
- Brossard, D.; Lewenstein, B.V. A Critical Appraisal of Models of Public Understanding of Science. In Communicating Science: New Agendas in Communication; Kahlor, L., Stout, P., Eds.; Routledge: New York, NY, USA, 2009; pp. 11–39. [Google Scholar]
- Selin, C.; Rawlings, K.C.; de Ridder-Vignone, K.; Sadowski, J.; Altamirano Allende, C.; Gano, G.; Davies, S.R.; Guston, D.H. Experiments in Engagement: Designing Public Engagement with Science and Technology for Capacity Building. Public Underst. Sci. 2017, 26, 634–649. [Google Scholar] [CrossRef]
- Bonney, R.; Shirk, J.L.; Phillips, T.B.; Wiggins, A.; Ballard, H.L.; Miller-Rushing, A.J.; Parrish, J.K. Citizen Science: Next Steps for Citizen Science. Science 2014, 343, 1436–1437. [Google Scholar] [CrossRef] [PubMed]
- Sharma, N.; Greaves, S.; Siddharthan, A.; Anderson, H.B.; Robinson, A.; Colucci-Gray, L.; Wibowo, A.T.; Bostock, H.; Salisbury, A.; Roberts, S.; et al. From Citizen Science to Citizen Action: Analysing the Potential for a Digital Platform to Cultivate Attachments to Nature. J. Sci. Commun. 2019, 18, 1–35. [Google Scholar] [CrossRef]
- Golumbic, Y.N.; Baram-Tsabari, A.; Fishbain, B. Engagement Styles in an Environmental Citizen Science Project. J. Sci. Commun. 2020, 19, A03. [Google Scholar] [CrossRef]
- Roche, J.; Bell, L.; Galvão, C.; Golumbic, Y.N.; Kloetzer, L.; Knoben, N.; Laakso, M.; Lorke, J.; Mannion, G.; Massetti, L.; et al. Citizen Science, Education, and Learning: Challenges and Opportunities. Front. Sociol. 2020, 5, 110. [Google Scholar] [CrossRef] [PubMed]
- Wilkinson, M.D.; Dumontier, M.; Aalbersberg, I.J.; Appleton, G.; Axton, M.; Baak, A.; Blomberg, N.; Boiten, J.W.; da Silva Santos, L.B.; Bourne, P.E.; et al. Comment: The FAIR Guiding Principles for Scientific Data Management and Stewardship. Sci. Data 2016, 3, 1–9. [Google Scholar] [CrossRef] [Green Version]
- Parsons, S.; Azevedo, F.; Elsherif, M.M.; Guay, S.; Shahim, O.N.; Govaart, G.H.; Norris, E.; O’Mahony, A.; Parker, A.J.; Todorovic, A.; et al. A Community-Sourced Glossary of Open Scholarship Terms. Nat. Hum. Behav. 2022, 6, 312–318. [Google Scholar] [CrossRef] [PubMed]
- Lewenstein, B.V. Is Citizen Science a Remedy for Inequality? Ann. Am. Acad. Pol. Soc. Sci. 2022, 700, 183–194. [Google Scholar] [CrossRef]
- Baruch, A.; May, A.; Yu, D. The Motivations, Enablers and Barriers for Voluntary Participation in an Online Crowdsourcing Platform. Comput. Human Behav. 2016, 64, 923–931. [Google Scholar] [CrossRef] [Green Version]
- Lee, J.; Kladwang, W.; Lee, M.; Cantu, D.; Azizyan, M.; Kim, H.; Limpaecher, A.; Yoon, S.; Treuille, A.; Das, R. RNA Design Rules from a Massive Open Laboratory. Proc. Natl. Acad. Sci. USA 2014, 111, 2122–2127. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saha, K.; Torous, J.; Ernala, S.K.; Rizuto, C.; Stafford, A.; De Choudhury, M. A Computational Study of Mental Health Awareness Campaigns on Social Media. Transl. Behav. Med. 2019, 9, 1197–1207. [Google Scholar] [CrossRef]
- Calimeri, F.; Cauteruccio, F.; Cinelli, L.U.C.A.; Marzullo, A.; Stamile, C.; Terracina, G.; Durand-Dubief, F.; Sappey-Marinier, D. A Logic-Based Framework Leveraging Neural Networks for Studying the Evolution of Neurological Disorders. Theory Pract. Log. Program. 2021, 21, 80–124. [Google Scholar] [CrossRef] [Green Version]
- Markauskaite, L.; Marrone, R.; Poquet, O.; Knight, S.; Martinez-Maldonado, R.; Howard, S.; Tondeur, J.; De Laat, M.; Buckingham Shum, S.; Gašević, D.; et al. Rethinking the Entwinement between Artificial Intelligence and Human Learning: What Capabilities Do Learners Need for a World with AI? Comput. Educ. Artif. Intell. 2022, 3, 100056. [Google Scholar] [CrossRef]
- Mahr, D.; Dickel, S. Citizen Science beyond Invited Participation: Nineteenth Century Amateur Naturalists, Epistemic Autonomy, and Big Data Approaches Avant La Lettre. Hist. Philos. Life Sci. 2019, 41, 1–19. [Google Scholar] [CrossRef] [PubMed]
- Lakeman-Fraser, P.; Gosling, L.; Moffat, A.J.; West, S.E.; Fradera, R.; Davies, L.; Ayamba, M.A.; Van Der Wal, R. To Have Your Citizen Science Cake and Eat It? Delivering Research and Outreach through Open Air Laboratories (OPAL). BMC Ecol. 2016, 16, 57–70. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Salmon, R.A.; Rammell, S.; Emeny, M.T.; Hartley, S. Citizens, Scientists, and Enablers: A Tripartite Model for Citizen Science Projects. Diversity 2021, 13, 309. [Google Scholar] [CrossRef]
- Kahle, K.; Sharon, A.J.; Baram-Tsabari, A. Footprints of Fascination: Digital Traces of Public Engagement with Particle Physics on CERN’s Social Media Platforms. PLoS ONE 2016, 11, e0156409. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Edney, S.; Bogomolova, S.; Ryan, J.; Olds, T.; Sanders, I.; Maher, C. Creating Engaging Health Promotion Campaigns on Social Media: Observations and Lessons From Fitbit and Garmin. J. Med. Internet Res. 2018, 20, e10911. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Database Title | Data Inputs |
---|---|
Essential medicine | Medicine from the Model List of Essential Medicines |
Active ingredient/s | Multiple active ingredients are separated by ‘;’ |
Trade name | Name given to a product that is registered by its owner as a trade mark |
Applicant holder | The company that has FDA approval to supply the product to the USA |
Market status | RX—prescription, OTC—over the counter, DISCN—discontinued |
Dosage form | Tablet, capsule, ointment, suspension, injectable, etc. |
Administration route | Oral, topical, buccal, injection, etc. |
Strength | Expressed as a mass in milligrams, e.g., 200 mg, mass per volume, e.g., 200 mg/mL, or mass equivalents if a base, e.g., 200 mg base |
FDA application type | N—new drug applications (innovator), A—abbreviated new drug applications (generics) |
FDA application number | Six-digit number |
FDA product number | If multiple products are applied for in a single application, each product is assigned a number |
FDA approval date | Day/Month/Year |
Under patent? | Yes or no |
Latest patent expiry date | Day/Month/Year |
Exclusivity agreement? | Yes or no |
Latest exclusivity expiry date | Day/Month/Year |
Platform | Views | Likes | Comments | Shares/Retweets | Total |
---|---|---|---|---|---|
3041 | 118 | 19 | 17 | 3195 | |
1476 | 362 | 48 | 47 | 1933 | |
3111 | 177 | 18 | 96 | 3402 | |
Total | 7628 | 657 | 85 | 160 | 8530 |
Essential Medicine | Year First Marketed | Marketed for | Dosage Form(s) | Common or Trade Names | Fun Fact | References |
---|---|---|---|---|---|---|
Rifampicin | 1968 (Italy) | antibiotic—TB specifically | oral | Rifampin | Named rifampicin because researchers liked a French movie named “Rififi” about jewel heists and gangs (French slang for brawl) | nature.com/articles/ja2014108 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Golumbic, Y.N.; Scroggie, K.R.; Kenneally, C.R.; Lin, J.; Blyth, M.T.; Firmer, G.; Rutledge, P.J.; Motion, A. Meet the Medicines—A Crowdsourced Approach to Collecting and Communicating Information about Essential Medicines Online. Int. J. Environ. Res. Public Health 2023, 20, 4242. https://doi.org/10.3390/ijerph20054242
Golumbic YN, Scroggie KR, Kenneally CR, Lin J, Blyth MT, Firmer G, Rutledge PJ, Motion A. Meet the Medicines—A Crowdsourced Approach to Collecting and Communicating Information about Essential Medicines Online. International Journal of Environmental Research and Public Health. 2023; 20(5):4242. https://doi.org/10.3390/ijerph20054242
Chicago/Turabian StyleGolumbic, Yaela N., Kymberley R. Scroggie, Ciara R. Kenneally, Jiarun Lin, Mitchell T. Blyth, Genevieve Firmer, Peter J. Rutledge, and Alice Motion. 2023. "Meet the Medicines—A Crowdsourced Approach to Collecting and Communicating Information about Essential Medicines Online" International Journal of Environmental Research and Public Health 20, no. 5: 4242. https://doi.org/10.3390/ijerph20054242